COVID-19 in 2025 is still circulating widely, but for most people it looks and feels more like a bad cold or flu than the severe respiratory illness that defined the early pandemic. The virus continues to evolve, immunity from vaccines and prior infections is widespread, and the overall risk of hospitalization and death is substantially lower than it was in 2020 or 2021. That said, COVID still sends people to the hospital, still causes lasting symptoms in a meaningful percentage of cases, and still warrants attention, especially if you’re older or have underlying health conditions.
What the Symptoms Feel Like Now
The most common symptoms of current COVID infections overlap heavily with colds and flu: sore throat, congestion, runny nose, cough, fatigue, and headache. Fever, body aches, and general malaise are still common but tend to be shorter-lived than in earlier waves. Some people also experience nausea, vomiting, or diarrhea.
Loss of taste and smell, the hallmark symptom that made early pandemic infections so distinctive, still shows up on the CDC’s official symptom list but is far less common with the variants circulating now. Most people who catch COVID today describe something that feels like a rough cold lasting five to ten days, with a day or two of more intense fatigue and body aches mixed in. Shortness of breath, which was a defining feature of the original and Delta waves, is less frequently reported in otherwise healthy people.
Emergency warning signs haven’t changed: trouble breathing, persistent chest pain or pressure, new confusion, or an inability to stay awake all warrant immediate medical attention.
Which Variants Are Circulating
The virus keeps mutating, but all currently circulating variants descend from the Omicron lineage that became dominant in late 2021. The WHO lists JN.1 as the current variant of interest, with several sublineages (including KP.3.1.1 and LP.8.1) under monitoring. In practical terms, these newer offshoots are incrementally better at evading immune defenses from past infections and vaccines, which is why reinfections remain common. They haven’t shown signs of causing more severe disease than their Omicron predecessors.
How Well Vaccines Are Working
The 2024-2025 updated COVID vaccine provides moderate protection, particularly against the worst outcomes. CDC data from September 2024 through January 2025 found the updated vaccine was about 33% effective at preventing emergency department or urgent care visits across all adults. For adults 65 and older without immune-compromising conditions, it was 46% effective against hospitalization. For immunocompromised older adults, that number dropped to around 40%.
Those numbers are lower than what many people expect from a vaccine, but they’re roughly in line with how flu vaccines perform in a typical season. The vaccines are doing their heaviest lifting against severe illness and death rather than preventing infection entirely. If you’re over 65, have chronic health conditions, or are immunocompromised, the updated vaccine meaningfully reduces your odds of ending up in the hospital.
Long COVID Is Still Happening
One of the most persistent concerns about COVID is the risk of symptoms that linger for weeks or months after the initial infection. A large meta-analysis published in 2025 estimated that about 36% of people with a confirmed COVID diagnosis experience some form of long COVID, though the range is enormous depending on how long COVID is defined and who’s being studied. Some studies put the figure as low as 3%, others as high as 80%.
The good news is that the risk appears to be trending downward. Studies published in 2024 estimated a pooled prevalence of about 34%, slightly lower than the 37-38% seen in studies from 2021 through 2023. The strongest risk factors for developing long-lasting symptoms are being unvaccinated (roughly double the odds), infection with a pre-Omicron variant (about 1.7 times the odds), and being female (about 1.5 times the odds). Vaccination and the shift to Omicron-lineage variants both appear to have reduced, though certainly not eliminated, the chances of prolonged illness.
Treatment Options If You Get Sick
The main antiviral treatment for COVID remains Paxlovid, an oral medication you take at home for five days. In clinical trials, it reduced the risk of hospitalization and death by nearly 90% in unvaccinated, high-risk individuals. It works by blocking a key step in the virus’s ability to copy itself inside your cells. Paxlovid is intended for people at higher risk of severe illness who are at least 12 years old and weigh at least 88 pounds. Its primary purpose is preventing hospitalization and death, not shortening the duration of mild symptoms, though some people do feel better faster on it.
Timing matters. Paxlovid needs to be started within the first five days of symptoms, so getting tested promptly is important if you think you’re at risk for severe illness. Two other treatments exist: another oral antiviral (molnupiravir) and an IV-based option (remdesivir) given over three days in a medical facility. For most people at low risk, the standard approach is rest, fluids, and over-the-counter symptom relief.
What to Do When You Test Positive
The CDC simplified its isolation guidance in early 2024, moving away from fixed five-day isolation periods. The current recommendation: stay home while you’re sick, and return to normal activities once your symptoms have been improving for at least 24 hours and any fever has been gone for a full day without fever-reducing medication. No more counting to a specific number of days.
After you resume normal activities, the CDC encourages five additional days of precautions: wearing a well-fitting mask around others, improving ventilation when indoors, keeping your distance when possible, and practicing good hand hygiene. You’re still shedding virus during this window, even if you feel mostly fine.
Home Tests Are Useful but Imperfect
Rapid antigen tests, the kind you swab at home, are still a practical first step for figuring out if you have COVID. But their accuracy depends heavily on timing. CDC research found that rapid tests peak in sensitivity around day three after symptoms start, when about 59% of tests come back positive (compared to 83% for lab-based PCR tests on the same day). On days when people had fever, the rapid test caught 77% of PCR-confirmed infections.
The bigger limitation is early in the infection. If you test the moment you feel a scratchy throat, you may get a false negative simply because the virus hasn’t built up enough in your nasal passages yet. On days with no symptoms, rapid test sensitivity drops to just 18% compared to PCR. If your first test is negative but you feel sick, testing again 24 to 48 hours later significantly improves your chances of catching a true positive. Serial testing, rather than relying on a single swab, gives you the most reliable picture.
The Bottom Line on Severity
COVID in 2025 is a less dangerous but more persistent part of life than it was during the pandemic’s peak years. Population-wide immunity from vaccination and prior infection has blunted the virus’s ability to cause severe illness in most people. But “milder on average” still leaves room for serious outcomes, particularly for older adults and those with weakened immune systems. The tools available, updated vaccines, antivirals, and rapid testing, work best when used proactively rather than after the window has closed.